For example, PD-L1-specific CAR-T cells, when used in conjunction with scFv-41BB-CD3-ζ and DC-activated T cells loaded with a CSC antigen, exhibited significant effect in killing cancer cells and reducing the tumor burden in mice, surpassing the effects of any single treatment (185). This evidence concerns the gene CD274 and cancer.